Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-11-13
2007-11-13
Huff, Sheela J. (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S007210, C435S007230, C435S007500, C435S007700, C435S007900, C435S007910, C436S518000
Reexamination Certificate
active
10083576
ABSTRACT:
A method for purifying cancer-specific Proliferating Cell Nuclear Antigen (csPCNA) is described, as well as an immunoassay based thereon.
REFERENCES:
patent: 4376110 (1983-03-01), David et al.
patent: 4486530 (1984-12-01), David et al.
patent: 4632901 (1986-12-01), Valkirs et al.
patent: 4727019 (1988-02-01), Valkirs et al.
patent: 5356817 (1994-10-01), Cole
patent: 5395754 (1995-03-01), Lambotte et al.
patent: 5574047 (1996-11-01), Bumol et al.
patent: 5580903 (1996-12-01), Mawatari et al.
patent: 5616461 (1997-04-01), Schaffer et al.
patent: 5756476 (1998-05-01), Epstein et al.
patent: 5889169 (1999-03-01), Beach et al.
patent: 6063575 (2000-05-01), Sekowski et al.
patent: 6093543 (2000-07-01), Coll et al.
patent: 6514713 (2003-02-01), Knott et al.
patent: 2006/0073477 (2006-04-01), Malkas
patent: 04012273 (1992-01-01), None
patent: 07191037 (1995-07-01), None
patent: 96/35715 (1996-11-01), None
Gary et al JBC vol. 272 p. 24522 (1997).—24529.
Ogata et al,J. of Immunol.,135(4):2623-2627 (1985).
Malkas, “A Cancer Specific Form of Proliferating Cell Nuclear Antigen (csPCNA) Is Present in Malignant Human Cells and Tissues”, Abstract, Presented at the MD Anderson Tumor Marker Meeting. Houston, Texas (Mar. 2001).
Macedo et al, “Investigations on the Mechanism of Action of Novel Acylhydrazones and Sulfonylhydrazones Derivatives”,Proceedings of the American Association for Cancer Research, Abstract No. 431, vol. 42, p. 80 (Mar. 2001).
Abdel-Aziz et al, “Effects of Cytosine Arabinoside, Camptotheein, and Etoposide on In Vitro DNA Replication Mediated by the Human Cancer Cell DNA Synthesome”,Proceedings of the American Association for Cancer Research, Abstract No. 541, vol. 42, p. 100 (Mar. 2001).
Tomie et al, “Detection of the Cancer Specific Form of PCNA by Elisa Assay”,Proceedings of the American Association for Cancer Research, Abstract No. 2507, vol. 42, p. 466 (Mar. 2001).
Smith et al, “Visualization of Cervical and Breast Cancer-Derived DNA Replication Complexes by Transmission Electron Microscopy”,Proceedings of the American Association for Cancer Research, Abstract No. 2795, vol. 42, p. 519 (Mar. 2001).
Lankford et al, “Proteomic Analysis of the Human Breast and Ovarian DNA Synthesome Associated Mismatch Repair Proteins”,Proceedings of the American Association for Cancer Research, Abstract No. 4797, vol. 42, p. 894 (Mar. 2001).
Hoelz et al, “Isolation and Characterization of the Non-Malignant Form of PCNA from MCF7 Breast Cancer Cells”,Proceedings of the American Association for Cancer Research, Abstract No. 4798, vol. 42, p. 894 (Mar. 2001).
Hicke et al, “The Human Cell DNA Synthesome: A Novel In Vitro Model System for Evaluating Anticancer Drug Action”, Abstract No. 137,Anticancer Research, 21:1577-1622 (2001).
Malkas et al, “Specific Functional and Structural Alteration of the Cancer Cells' DNA Replication Apparatus: Potential New Targets for Drug Development”, Abstract No. 152,Anticancer Research, 21:1577-1622 (2001).
Hoelz et al,“Differential Binding of p21WAFIby an Altered Form of PCNA Present in Breast Cancer Cells”, Abstract, San Antonio Breast Cancer Symposium (Dec. 2001).
Bechtel et al,Advances in Brief, Cancer Research, 58:3264-3269 (1998).
Beyne-Rauzy et al., “Anti-PCNA Antibodies: Prevalence and Predictive Value,” Joint Bone Spine 72:430-36 (2005).
Brand et al., “Autoreactive Epitope Profiles of the Proliferating Cell Nuclear Antigen Define Two Classes of Autoantibodies,” J. Immunol. 152:4120-28 (1994).
Dobrolecki et al., Abstract No. 3546 AACR (2004).
Fukuda et al., “Structure-Function Relationship of the Eukaryotic DNA Replication Factor, Proliferating Cell Nuclear Antigen” J. Biol. Chem. 270:22527-34 (1995).
Hoelz et al., “Cancer Specific Proliferating Cell Nuclear Antigen as a Novel Diagnostic Marker for the Detection of Breast Cancer” Abstract http://cdmrp.army.mil/bcrp/era/abstracts2005/0210467—abs.pdf (2005).
Hoelz, “Cancer Specific Proliferating Cell Nuclear Antigen as a Novel Diagnostic Marker for the Detection of Breast Cancer—Annual Summary Rept. Oct. 1 2002-Sep. 30, 2003” Abstract http://www.ntis.gov/search/product.asp?ABBR=ADA422005&starDB=GRAHIST.
Kelman, “PCNA: Structure, Functions and Interactions” Oncogene 14:629-40 (1997).
Ino et al., “Expression of Proliferating Cell Nuclear Antigen (PCNA) in the Adult and Developing Mouse Nervous System” Mol. Brain Res. 78:163-74 (2000).
Roos et al., “Determination of the Epitope of an Inhibitory Antibody to Proliferating Cell Nuclear Antigen” Experimental Cell Res. 226:208-13 (1996).
Tzang et al., “Presentation of Autoantibody to Proliferating Cell Nuclear Antigen in Patients with Chronic Hepatitis B and C Virus Infection” Ann. Rheum Dis. 58:630-34 (1999).
Warbrick, “The Puzzle of PCNA's Many Partners” BioEssays 22:997-1006 (2000).
Zhang et al., “The Interdomain Connector Loop of Human PCNA Is Involved in a Direct Interaction with Human Polymerase σ” J. Biol. Chem. 273:713-19 (1998).
Malkas et al., “A Cancer-Specific Form of Proliferating Cell Nuclear Antigen (csPCNA) Is Present in Malignant Human Breast Cells and Tissues” J. Clin. Ligang Assay 25:20-32 (2002).
Hoelz et al., “The Discovery of Labile Methyl Esters on Proliferating Cell Nuclear Antigen by MS/MS” Proteomics 6:4808-16 (2006).
Naryzhny et al., “Observation of Multiple Isoforms and Specific Proteolysis Patterns of Proliferating Cell Nuclear Antigen in the Context of Cell Cycle Compartments and Sample Preparations” Proteomics 3:930-36 (2003).
Almendral et al, Proc. Natl. Acad. Sci., USA, 84:1575-1579(1987).
Applegreen et al, J. of Cell Biochem, 59:91-107 (1995).
Bechtel et al, Proc. of the American Association for Cancer Research, 37:494 (1996).
Brown, Breast Cancer, Hematology/Oncology Clinics of North America, 8(1):101-112 (1994).
Coll et al, Oncology Research, 8(10-11):435-447 (1996).
Coll et al, Oncology Research, 9:629-639 (1997).
Gabizon et al, Cancer Research, 52:891-896 (1992).
Genesis Group Associates, Inc., New tests improve breast cancer prognosis, Genesis Report-Dx, vol. 6, No. 3, NLDB Accession No. 97-320100 (1997).
Hickey et al, “DNA Replication and Mutagenesis”, American Soc. for Microbiology, Washington, D.C., pp. 41-54 (1998).
Hickey et al, Critical Reviews in Eukaryotic Gene Expression, 7(1&2):125-157 (1997).
Kang et al, Carcinogenesis, 18(2):251-257 (1997).
Kirpotin et al, Biochemistry, 36:66-75 (1997).
Lasic et al, Science, 267:1275-1276 (1995).
Levenson et al, Cancer Research, 57:3071-3078 (1997).
Lin et al, Cell Growth & Differentiation, 8:1359-1369 (1997).
Lin et al, Leukemia Research, 21(6):501-512 (1997).
Malkas et al, Biochemistry, 29(27):6362-6374 (1990).
Ogata et al, The J. of Immunol., 135(4):2623-2627 (1985).
Papahadjopoulus et al, Proc. Natl. Acad. Sci., USA, 88:11460-11464 (1991).
Park et al, Proc. Natl. Acad. Sci., USA, 92:1327-1331 (1995).
Pohl et al., Neural network evaluation of multiple tumor markers for diagnosis of ovarian cancer (Meeting Abstract), Non-serial, 3rd International Conference of the Mediterranean Society of Tumor Marker Oncology, CANCERLIT Accession No. 95614997 (1994).
Sekowski et al, Toxicology and Applied Pharmacology, 145:268-276 (1997).
Simbulan-Rosenthal et al, Biochem, 35(36):11622-11633 (1996).
Soule et al, Cancer Research, 50:6075-6086 (1990).
Soule et al, J. of the Natl. Cancer Inst., 51(5):1409-1413 (1973).
Stampfer, J. of Tissue Culture Methods, 9(2):107-115 (1985).
Tait et al, Cancer Research, 50:6087-6094 (1990).
Tockman et al, Cancer Research, 52 (Suppl.):2711s-2718s (1992).
Tom et al, J. of Cell. Biochem., 63:259-267 (1996).
Ward, Developmental Oncology, 21:90-106 (1985).
Waseem et al, J. of Cell Science, 96(1):121-129 (1990).
Winter et al, Ann. Rev. Immunol., 12:433-455 (1994).
Sekowski et al, C
Bechtel Pamela E.
Hickey Robert J.
Hoelz Derek J.
Malkas Linda H.
Park Min
csKeys, LLC
Huff Sheela J.
Rueppell R. Christopher
Whiteford, Taylor & Preston, LLC
LandOfFree
Method for purifying cancer-specific proliferating cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for purifying cancer-specific proliferating cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for purifying cancer-specific proliferating cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3883348